Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.54 -0.09 (-2.48%)
As of: Sep 29, 2026 · 1:57 PM EDT

Galmed Pharmaceuticals (EOCN) EV to EBIT (2014 - 2024)

Updated

Galmed Pharmaceuticals' (EOCN) EV to EBIT came in at -5.66 for FY2025, compared with -2.17 in FY2024.

Analysis

Galmed Pharmaceuticals (EOCN) EV to EBIT (2014 - 2024) Analysis & Trends

Since FY2014, Galmed Pharmaceuticals has reported EV to EBIT for 12 years.

  • The FY2025 figure stands as the lowest annual EV to EBIT in data going back to FY2014.
  • Business Quant data shows EOCN's EV to EBIT at -2.17 in FY2024, -1.23 in FY2023, -0.12 in FY2022 and 0.20 in FY2021 (-39.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Galmed Pharmaceuticals 422,361.40 422,361.40 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -8.83
Jun 30, 2023 -222.00
Mar 31, 2023 -0.21
Jun 30, 2022 -0.58
Mar 31, 2022 0.55
Jun 30, 2020 2.17
Mar 31, 2020 1.40
Dec 31, 2019 4.55
Sep 30, 2019 2.36
Jun 30, 2019 6.10
Mar 31, 2019 7.60
Dec 31, 2018 6.70
Sep 30, 2018 11.00
Jun 30, 2018 14.34
Mar 31, 2018 6.68
Dec 31, 2017 10.46
Sep 30, 2017 8.06
Jun 30, 2017 5.07
Mar 31, 2017 3.60
Dec 31, 2016 2.34
API Access

Galmed Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=EOCN&period=max&api_key=YOUR_API_KEY